Back to NATIONAL BANK OF CANADA /FI/ NATIONAL BANK OF CANADA /FI/

ATONATON
8 quarters

Position history for NATIONAL BANK OF CANADA /FI/NATIONAL BANK OF CANADA /FI/'s holdings in PORTAGE BIOTECH INC

No. National Bank of Canada exited its ATON (Portage Biotech) position in Q2 2026. Its Q1 2026 13F listed 73 shares worth $24. National Bank of Canada first reported ATON in Q3 2024 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$485

Total Shares Change

-73

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$12.70
0
2026-Q1
Unchanged
73
0.0%
$240.0%$15.80
0
2025-Q4
Unchanged
73
0.0%
$430.0%$30.00
0
2025-Q3
Unchanged
73
0.0%
$3900.0%$269.50
0
2025-Q2
Unchanged
73
0.0%
$4020.0%$276.00
0
2025-Q1
Unchanged
73
0.0%
$6530.0%$462.50
0
2024-Q4
Unchanged
73
0.0%
$3770.0%$258.50
0
2024-Q3
New
73
-
$4850.0%$332.50
17

Other major holders of ATON: JANE STREET GROUP, LLC, MORGAN STANLEY, UBS Group AG, CITADEL ADVISORS LLC, Virtu Financial LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used